Clinical Trials Browser

Phase 2 × Drug-Related Side Effects and Adverse Reactions × icotinib × Clear all

NCT01963195 2017-05-08

Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy

Phase 2 Unknown

Drug-Related Side Effects and Adverse Reactions